DaVita Inc
DVA
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.27B
Close$
$301.72
59.5% upside
Current Fair Value
59.5% upsideUndervalued by 59.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.27 Billion |
|---|---|
| Enterprise Value | $22.41 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $9.72 |
| Beta | 0.8 |
| Outstanding Shares | 64,781,000 |
Return
| Return on Equity | -110.77% |
|---|---|
| Return on Assets | 4.79% |
| Return on Invested Capital | 11.80% |
Valuation & Multiples
| P/E Ratio | 15.41 |
|---|---|
| PEG | 46.51 |
| Price to Sales | 0.88 |
| Price to Book Ratio | 11.82 |
| Enterprise Value to Revenue | 1.6 |
| Enterprise Value to EBIT | 12.79 |
| Enterprise Value to Net Income | 26 |
| Total Debt to Enterprise | 0.48 |
| Debt to Equity | -14.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$3.88
Average shareholder expectationRevenue Estimate
$3.50 B
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
$3.57
Average shareholder expectationRevenue Estimate
$3.52 B
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 44.54% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.04%▼ 91.62% |
|---|---|
| Total Invested | $4.21M▼ 99.97% |
| Investors Holding | 17▼ 648.00% |
ESG Score
No data
About DaVita Inc
78,000 employees
CEO: Javier Rodriguez DaVita Inc. specializes in delivering vital kidney dialysis treatments to individuals afflicted with chronic kidney failure. The company manages numerous outpatient dialysis clinics, where it not only conducts dialysis sessions but also ...